Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2017

Fowler F, Tyler JK. Anchoring Chromatin Loops to Cancer. Dev Cell. 2017;42(3):209-211.

Hang J-, Siddiqui MT, Ali SZ. Fine Needle Aspiration of Langerhans Cell Histiocytosis: A Cytopathologic Study of 37 Cases. Acta Cytol. 2017;61(2):96-102.

Gullett JC, Westblade LF, Green DA, Whittier S, Burd EM. Closing the Brief Case: Too Beta To Be a "B". J Clin Microbiol. 2017;55(6):1973-1974.

Dinerman BF, Bernstein AN, Khani F, Hu JC. Intraductal Carcinoma of the Prostate: A Risk for Rapid Recurrence. Urology. 2017;105:e1-e2.

Meliti A, Sadimin E, Diolombi M, Khani F, Epstein JI. Accuracy of Grading Gleason Score 7 Prostatic Adenocarcinoma on Needle Biopsy: Influence of Percent Pattern 4 and Other Histological Factors. Prostate. 2017;77(6):681-685.

Magro CM, Momtahen S, Kiuru M. Primary Cutaneous Small Cell Variant of Anaplastic Large Cell Lymphoma: A Case Series and Review of the Literature. Am J Dermatopathol. 2017;39(12):877-889.

Mereu E, Pellegrino E, Scarfò I, Inghirami G, Piva R. The heterogeneous landscape of ALK negative ALCL. Oncotarget. 2017;8(11):18525-18536.

Abate F, da Silva-Almeida AC, Zairis S, Robles-Valero J, Couronne L, Khiabanian H, et al. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas. Proc Natl Acad Sci U S A. 2017;114(4):764-769.

Calvert AE, Chalastanis A, Wu Y, Hurley LA, Kouri FM, Bi Y, et al. Cancer-Associated IDH1 Promotes Growth and Resistance to Targeted Therapies in the Absence of Mutation. Cell Rep. 2017;19(9):1858-1873.

Ely S, Forsberg P, Ouansafi I, Rossi A, Modin A, Pearse R, et al. Cellular Proliferation by Multiplex Immunohistochemistry Identifies High-Risk Multiple Myeloma in Newly Diagnosed, Treatment-Naive Patients. Clin Lymphoma Myeloma Leuk. 2017;17(12):825-833.